These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 2146210)
1. T-cell clones that react against autologous human tumors. Mukherji B; Chakraborty NG; Sivanandham M Immunol Rev; 1990 Aug; 116():33-62. PubMed ID: 2146210 [TBL] [Abstract][Full Text] [Related]
2. Clonal analysis of cytotoxic and regulatory T cell responses against human melanoma. Mukherji B; Guha A; Chakraborty NG; Sivanandham M; Nashed AL; Sporn JR; Ergin MT J Exp Med; 1989 Jun; 169(6):1961-76. PubMed ID: 2471770 [TBL] [Abstract][Full Text] [Related]
3. Selective expansion of a specific anti-tumor CD8+ cytotoxic T lymphocyte clone in the bulk culture of tumor-infiltrating lymphocytes from a melanoma patient: cytotoxic activity and T cell receptor gene rearrangements. Gervois N; Heuze F; Diez E; Jotereau F Eur J Immunol; 1990 Apr; 20(4):825-31. PubMed ID: 1971794 [TBL] [Abstract][Full Text] [Related]
4. Tumor specific cytolysis by tumor infiltrating lymphocytes in breast cancer. Baxevanis CN; Dedoussis GV; Papadopoulos NG; Missitzis I; Stathopoulos GP; Papamichail M Cancer; 1994 Aug; 74(4):1275-82. PubMed ID: 7914469 [TBL] [Abstract][Full Text] [Related]
5. Human allogeneic melanoma-reactive T-helper lymphocyte clones: functional analysis of lymphocyte-melanoma interactions. Radrizzani M; Benedetti B; Castelli C; Longo A; Ferrara GB; Herlyn M; Parmiani G; Fossati G Int J Cancer; 1991 Dec; 49(6):823-30. PubMed ID: 1835714 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the functional capabilities of CD3+CD4-CD8- and CD3+CD4+CD8+ human T cell clones. Patel SS; Wacholtz MC; Duby AD; Thiele DL; Lipsky PE J Immunol; 1989 Aug; 143(4):1108-17. PubMed ID: 2526180 [TBL] [Abstract][Full Text] [Related]
7. Cloned human cytotoxic T lymphocyte (CTL) lines reactive with autologous melanoma cells. I. In vitro generation, isolation, and analysis to phenotype and specificity. de Vries JE; Spits H J Immunol; 1984 Jan; 132(1):510-9. PubMed ID: 6197458 [TBL] [Abstract][Full Text] [Related]
8. Differences in surface phenotype and mechanism of action between alloantigen-specific CD8+ cytotoxic and suppressor T cell clones. Koide J; Engleman EG J Immunol; 1990 Jan; 144(1):32-40. PubMed ID: 1967266 [TBL] [Abstract][Full Text] [Related]
9. Characterization of human autotumor-reactive T-cell clones obtained from tumor-infiltrating lymphocytes in liver metastasis of gastric carcinoma. Shimizu Y; Weidmann E; Iwatsuki S; Herberman RB; Whiteside TL Cancer Res; 1991 Nov; 51(22):6153-62. PubMed ID: 1718596 [TBL] [Abstract][Full Text] [Related]
10. Measles virus-specific human T cell clones. Characterization of specificity and function of CD4+ helper/cytotoxic and CD8+ cytotoxic T cell clones. van Binnendijk RS; Poelen MC; de Vries P; Voorma HO; Osterhaus AD; Uytdehaag FG J Immunol; 1989 Apr; 142(8):2847-54. PubMed ID: 2467943 [TBL] [Abstract][Full Text] [Related]
11. Composite response of naive T cells to stimulation with the autologous lymphoblastoid cell line is mediated by CD4 cytotoxic T cell clones and includes an Epstein-Barr virus-specific component. Misko IS; Sculley TB; Schmidt C; Moss DJ; Soszynski T; Burman K Cell Immunol; 1991 Feb; 132(2):295-307. PubMed ID: 1846323 [TBL] [Abstract][Full Text] [Related]
12. MHC class-I-restricted auto-tumor-specific CD4+CD8- T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC). Wang P; Vánky F; Klein E Int J Cancer; 1992 Jul; 51(6):962-7. PubMed ID: 1386348 [TBL] [Abstract][Full Text] [Related]
13. Interplay between the TCR/CD3 complex and CD4 or CD8 in the activation of cytotoxic T lymphocytes. de Vries JE; Yssel H; Spits H Immunol Rev; 1989 Jun; 109():119-41. PubMed ID: 2527803 [TBL] [Abstract][Full Text] [Related]
14. Antigen specific and MHC nonrestricted cytotoxicity of T cell receptor alpha beta+ and gamma delta+ human T cell clones isolated in IL-4. Paliard X; Yssel H; Blanchard D; Waitz JA; deVries JE; Spits H J Immunol; 1989 Jul; 143(2):452-7. PubMed ID: 2472439 [TBL] [Abstract][Full Text] [Related]
15. Clonal analysis of in vivo activated CD8+ cytotoxic T lymphocytes from a melanoma patient responsive to active specific immunotherapy. Kan-Mitchell J; Huang XQ; Steinman L; Oksenberg JR; Harel W; Parker JW; Goedegebuure PS; Darrow TL; Mitchell MS Cancer Immunol Immunother; 1993 Jul; 37(1):15-25. PubMed ID: 8513449 [TBL] [Abstract][Full Text] [Related]
16. Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. Itoh K; Platsoucas CD; Balch CM J Exp Med; 1988 Oct; 168(4):1419-41. PubMed ID: 3262710 [TBL] [Abstract][Full Text] [Related]
17. Human CD4-8- -derived clones. Phenotypic and functional characteristics and variation between donors in patterns of T-cell receptor gamma gene rearrangements. Christmas SE Scand J Immunol; 1989 Jun; 29(6):699-708. PubMed ID: 2544987 [TBL] [Abstract][Full Text] [Related]
18. CD4+ T cell clones isolated from human renal cell carcinoma possess the functional characteristics of Th2 helper cells. Schoof DD; Terashima Y; Peoples GE; Goedegebuure PS; Andrews JV; Richie JP; Eberlein TJ Cell Immunol; 1993 Aug; 150(1):114-23. PubMed ID: 8102084 [TBL] [Abstract][Full Text] [Related]
19. Alloantigen-specific cytotoxic clones bearing the alpha,beta T cell antigen receptor but not CD4 or CD8 molecules. Rivas A; Koide J; Laus R; Engleman EG J Immunol; 1990 Jul; 145(2):470-6. PubMed ID: 2142178 [TBL] [Abstract][Full Text] [Related]
20. Antigen recognition by human T cell receptor gamma-positive lymphocytes. Specific lysis of allogeneic cells after activation in mixed lymphocyte culture. Ciccone E; Viale O; Bottino C; Pende D; Migone N; Casorati G; Tambussi G; Moretta A; Moretta L J Exp Med; 1988 Apr; 167(4):1517-22. PubMed ID: 2965741 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]